Teva Announces FDA Acceptance of Reslizumab For Asthma
News
Teva Pharmaceutical Industries Ltd., a leading global pharmaceutical company, recently announced that the FDA has accepted reslizumab, the company’s investigational drug, for review for the Biologics License Application (BLA). The ... Read more